- Home
- LPTX vs MAMO Comparison
LPTX vs MAMO Comparison
Compare LPTX & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- MAMO
- Stock Information
- Founded
- LPTX 2011
- MAMO 2008
- Country
- LPTX United States
- MAMO United States
- Employees
- LPTX N/A
- MAMO N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- MAMO
- Sector
- LPTX Health Care
- MAMO
- Exchange
- LPTX Nasdaq
- MAMO NYSE
- Market Cap
- LPTX 119.6M
- MAMO 113.4M
- IPO Year
- LPTX N/A
- MAMO 2024
- Fundamental
- Price
- LPTX $0.39
- MAMO $2.79
- Analyst Decision
- LPTX Buy
- MAMO
- Analyst Count
- LPTX 3
- MAMO 0
- Target Price
- LPTX $8.50
- MAMO N/A
- AVG Volume (30 Days)
- LPTX 321.2K
- MAMO 49.0K
- Earning Date
- LPTX 05-12-2025
- MAMO 04-15-2025
- Dividend Yield
- LPTX N/A
- MAMO N/A
- EPS Growth
- LPTX N/A
- MAMO N/A
- EPS
- LPTX N/A
- MAMO 0.18
- Revenue
- LPTX N/A
- MAMO $130,710,373.00
- Revenue This Year
- LPTX N/A
- MAMO N/A
- Revenue Next Year
- LPTX N/A
- MAMO N/A
- P/E Ratio
- LPTX N/A
- MAMO $15.19
- Revenue Growth
- LPTX N/A
- MAMO 30.14
- 52 Week Low
- LPTX $0.39
- MAMO $2.42
- 52 Week High
- LPTX $4.79
- MAMO $4.66
- Technical
- Relative Strength Index (RSI)
- LPTX 18.56
- MAMO N/A
- Support Level
- LPTX $0.40
- MAMO N/A
- Resistance Level
- LPTX $0.46
- MAMO N/A
- Average True Range (ATR)
- LPTX 0.03
- MAMO 0.00
- MACD
- LPTX 0.06
- MAMO 0.00
- Stochastic Oscillator
- LPTX 0.00
- MAMO 0.00
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About MAMO MASSIMO GROUP
Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).